Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management

HUMAN GENE THERAPY · Published 2026-02-12 · DOI 10.1177/10430342261423168

Authors being retrieved — see the publisher record. https://doi.org/10.1177/10430342261423168

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy · HUMAN GENE THERAPY · 2026 · Cites or is cited by this article · Same journal
Retroviral Transduction of Human CD4 + T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells · HUMAN GENE THERAPY · 2026 · Same journal
Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors · HUMAN GENE THERAPY · 2026 · Same journal
Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta ) · HUMAN GENE THERAPY · 2026 · Same journal
High Prevalence of Preexisting Neutralizing Antibodies Against Adeno-Associated Virus Capsids in Mongolian People with Hemophilia · HUMAN GENE THERAPY · 2026 · Same journal
Quantification of Lentiviral Vectors with Nucleic Acid Dyes · HUMAN GENE THERAPY · 2026 · Same journal
CAR-T Cell Therapy: Manufacturing Platforms and Clinical Consequences · HUMAN GENE THERAPY · 2026 · Same journal
A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential Solutions · HUMAN GENE THERAPY · 2026 · Same journal
Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases · HUMAN GENE THERAPY · 2026 · Same journal
Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing · HUMAN GENE THERAPY · 2026 · Same journal